Emerging Trends in Kidney Disease

Dear Colleagues,

The field of nephrology is experiencing an unprecedented era of discovery and innovation, making it an incredibly exciting time for researchers and clinicians. Recent advances in our understanding of kidney disease are leading to breakthroughs in diagnosis, treatment, and patient care, and we are thrilled to highlight these developments in a Special Issue of Biomedicines.

In the area of glomerular diseases and vasculitis, novel therapeutic agents are emerging that target specific molecular pathways, offering new hope for patients with previously refractory conditions. For instance, advancements in the treatment of IgA nephropathy and ANCA-associated vasculitis showcase the potential of precision medicine in nephrology.

Dialysis care is also evolving rapidly with innovations that challenge old assumptions and improve patient outcomes. New strategies for advancing care planning and managing dialysis-related complications set new standards for patient safety and quality of life.

In transplantation, the groundbreaking xenotransplantation trials mark significant progress in this field.

Pediatric nephrology is making significant strides, highlighting the importance of early intervention, in particular, pioneering treatments for severe congenital conditions that can improve survival rates.

These advancements underscore a vibrant period of innovation in nephrology. We invite you to contribute to this Special Issue of Biomedicines, sharing your research findings, clinical insights, and innovative approaches. Your contributions will help shape the future of kidney disease treatment and management, advancing scientific knowledge and significantly impacting patient care and outcomes.

Dr. Andrea Angioi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• kidney disease
• glomerular diseases
• vasculitis
• dialysis
• hypertension
• pediatric nephrology
• transplantation
• precision medicine
• therapeutic advancements